Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novartis
Novartis
BeiGene to go solo with cancer drug after Novartis deal termination
Yahoo/Reuters
Tue, 09/19/23 - 10:30 am
BeiGene
Novartis
cancer
tislelizumab
Tivimbra
Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Bausch + Lomb
Novartis
M&A
Xiidra
Novartis recalls Sandimmune oral solution due to crystal formation
Pharmaceutical Technology
Tue, 09/12/23 - 07:14 pm
Novartis
product recalls
Sandimmune
organ transplants
Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
BioSpace
Mon, 09/11/23 - 12:28 pm
Novartis
GT005
gene therapy
geographic atrophy
Gyroscope Therapeutics
Patent cliffs, divestitures and maturing biotechs all point to more pharma M&A: analysts
Fierce Pharma
Fri, 09/8/23 - 10:29 am
M&A
patent cliffs
Merck
JNJ
Pfizer
GSK
Novartis
Eli Lilly
Novo Nordisk
The 10 highest value R&D projects in biopharma
Fierce Biotech
Wed, 09/6/23 - 10:17 am
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Novartis names new board member after international boss steps down
Reuters
Wed, 09/6/23 - 10:06 am
Novartis
executives
Patrick Horber
Marie-France Tschudin
Novartis files suit against IRA after blockbuster Entresto makes CMS' price negotiations list
Fierce Pharma
Tue, 09/5/23 - 08:54 pm
Novartis
legal
Inflation Reduction Act
CMS
drug pricing
Entresto
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Motley Fool
Tue, 09/5/23 - 08:39 pm
Novartis
biosimilars
Eylea
Novartis updates on Sandoz finances ahead of spin-off
Pharmaphorum
Tue, 09/5/23 - 11:18 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Novartis hits back at Entresto selection on Medicare list
Pharmaphorum
Wed, 08/30/23 - 10:01 am
Novartis
Entresto
drug pricing
Medicare
Novartis: Leqvio Provides Low-density Lipoprotein Cholesterol Reduction Beyond 6 Years Of Treatment
RTT News
Mon, 08/28/23 - 12:05 pm
Novartis
Leqvio
LDL cholesterol
clinical trials
Novartis Abandons Xoma-Partnered Antibody for Pancreatic Cancer
BioSpace
Mon, 08/28/23 - 11:39 am
Novartis
Xoma
NIS793
pancreatic cancer
FDA Decisions 2023: Sandoz, Gilead Sciences and More
BioSpace
Fri, 08/25/23 - 11:31 am
FDA
Sandoz
Novartis
Gilead Sciences
Pfizer
Neurocrine
Regeneron
Ipsen
Revance Therapeutics
Delcath Systems
Janssen
Galera Therapeutics
Biogen
Roche
Mesoblast
Taiho Oncology
The Biopharma Patent Cliff: 9 Drugs Losing Exclusivity by the End of 2023
BioSpace
Wed, 08/23/23 - 11:11 am
patent cliff
patents
Takeda
Vyvanse
Pfizer
Eraxis
JNJ
Stelara
Merck
Isentress
Eiger Pharmaceuticals
Zokinvy
Astellas
Myrbetriq
Novartis
Entresto
Amgen
Otzela
Novartis to lay off another 100-plus employees at US HQ as global restructuring rolls on
Fierce Pharma
Tue, 08/22/23 - 11:38 pm
Novartis
layoffs
New Jersey
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
Tue, 08/22/23 - 09:58 am
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Novartis cites strong sales growth for $15B Sandoz spin-off as board vote unanimously for separation
Biopharma Reporter
Mon, 08/21/23 - 06:50 pm
Novartis
Sandoz
spinoff
biosimilars
generics
Novartis floats share distribution scheme as it plots Sandoz spinoff for Oct. 4
Fierce Pharma
Fri, 08/18/23 - 11:29 am
Novartis
Sandoz
spinoffs
generics
biosimilars
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »